335 related articles for article (PubMed ID: 32671650)
1. SARS-CoV-2/COVID-19: a primer for cardiologists.
de Vries AAF
Neth Heart J; 2020 Jul; 28(7-8):366-383. PubMed ID: 32671650
[TBL] [Abstract][Full Text] [Related]
2. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies.
Sharma A; Tiwari S; Deb MK; Marty JL
Int J Antimicrob Agents; 2020 Aug; 56(2):106054. PubMed ID: 32534188
[TBL] [Abstract][Full Text] [Related]
3. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
4. Current Strategies of Antiviral Drug Discovery for COVID-19.
Mei M; Tan X
Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
[TBL] [Abstract][Full Text] [Related]
5. Severe Acute Respiratory Syndrome Coronavirus 2: Manifestations of Disease and Approaches to Treatment and Prevention in Humans.
Watson ME; Inagaki K; Weinberg JB
Comp Med; 2021 Oct; 71(5):342-358. PubMed ID: 34535198
[TBL] [Abstract][Full Text] [Related]
6. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
7. The novel zoonotic COVID-19 pandemic: An expected global health concern.
Contini C; Di Nuzzo M; Barp N; Bonazza A; De Giorgio R; Tognon M; Rubino S
J Infect Dev Ctries; 2020 Mar; 14(3):254-264. PubMed ID: 32235085
[TBL] [Abstract][Full Text] [Related]
8. COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods.
Marofi F; Azizi R; Motavalli R; Vahedi G; Nasimi M; Yousefi M; Motavalli Y; Tahmasebi S; Gharibi T; Mohammed RN; Etemadi J; Khiavi FM
Anticancer Agents Med Chem; 2021 Oct; 21(16):2142-2162. PubMed ID: 33563186
[TBL] [Abstract][Full Text] [Related]
9. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.
Li YC; Bai WZ; Hashikawa T
J Med Virol; 2020 Jun; 92(6):552-555. PubMed ID: 32104915
[TBL] [Abstract][Full Text] [Related]
10. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
11. Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics.
Kumar V
Int Immunopharmacol; 2020 Nov; 88():106980. PubMed ID: 33182073
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
Elife; 2022 Feb; 11():. PubMed ID: 35191378
[TBL] [Abstract][Full Text] [Related]
13. A Review of SARS-CoV-2 and the Ongoing Clinical Trials.
Tu YF; Chien CS; Yarmishyn AA; Lin YY; Luo YH; Lin YT; Lai WY; Yang DM; Chou SJ; Yang YP; Wang ML; Chiou SH
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290293
[TBL] [Abstract][Full Text] [Related]
14. Wuhan 3 years after the outbreak of the pandemic-cardiological insights and perspectives.
Chen C; He W; Wang DW
Herz; 2023 Jun; 48(3):173-179. PubMed ID: 37106075
[TBL] [Abstract][Full Text] [Related]
15. Universal screening for SARS-CoV-2 infection: a rapid review.
Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
[TBL] [Abstract][Full Text] [Related]
16. The outlook for diagnostic purposes of the 2019-novel coronavirus disease.
Tahmasebi S; Khosh E; Esmaeilzadeh A
J Cell Physiol; 2020 Dec; 235(12):9211-9229. PubMed ID: 32452050
[TBL] [Abstract][Full Text] [Related]
17. Lethal zoonotic coronavirus infections of humans - comparative phylogenetics, epidemiology, transmission, and clinical features of coronavirus disease 2019, The Middle East respiratory syndrome and severe acute respiratory syndrome.
Hui DS; Zumla A; Tang JW
Curr Opin Pulm Med; 2021 May; 27(3):146-154. PubMed ID: 33660619
[TBL] [Abstract][Full Text] [Related]
18. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.
Bchetnia M; Girard C; Duchaine C; Laprise C
J Infect Public Health; 2020 Nov; 13(11):1601-1610. PubMed ID: 32778421
[TBL] [Abstract][Full Text] [Related]
19. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
